Drug
Adefovir clinical trials
- studies test it
- 22
- open now
- 0
- in phase 3
- 4
- first study started
- 2001
How studies write it
Studies that test it under each name
Studies by the year they started
19 studies that test it; most in 2010 (4)
| Year | Studies |
|---|---|
| 2001 | 2 |
| 2004 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 3
- Phase 3
- 4
- Phase 4
- 12
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 12 · Other 10
Bristol-Myers Squibb (3) · Bukwang Pharmaceutical (2) · Korea University (2) · Gilead Sciences (2) · Pharmasset (2) · Nanfang Hospital, Southern Medical University (2) · University of Cologne (1) · Akebia Therapeutics (1)
Often tested with
Tested in the same studies.
Entecavir (7) · Lamivudine (5) · Clevudine (4) · Tenofovir (3) · Telbivudine (3) · Pitavastatin (1) · Sitagliptin (1) · Vadadustat (1)
Studies
Open first, then newest update. How each study uses adefovir is read from its arms, and is right about nine times in ten.
Testing it · 22
- Drug Transporter Interaction Study PHENTRA_2015_KPUKCompletedPhase 4University of CologneNCT02743260Written as Adefovir
- Drug-Drug Interaction Study of Vadadustat With Digoxin, Adefovir and FurosemideCompletedPhase 1Akebia TherapeuticsNCT03801759Written as Adefovir
- A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis BCompletedPhase 4Hoffmann-La RocheNCT00922207Written as Adefovir
- Lamivudine and Adefovir to Treat Chronic Hepatitis BCompletedPhase 2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT00023309Written as Lamivudine and adefovir
- An Exploratory Study of RGT Strategy on Optimal NUC-experienced PatientsStatus unknownPhase 4Ruijin HospitalNCT02560649Written as Peginterferon alfa-2a plus Adefovir
- Entecavir Plus Adefovir in Lamivudine-Resistant PatientsWithdrawnPhase 4Bristol-Myers SquibbNCT00986778Written as Adefovir
- Trial of Telbivudine Combination Therapy vs. Continued Adefovir MonotherapyWithdrawnPhase 4Novartis PharmaceuticalsNCT00409019Written as Adefovir
- A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Proportion to Roadmap Concept in Patients With HBV Associated-HCCCompletedPhase 4Bukwang PharmaceuticalNCT01263002Written as clevudine, Adefovir
- A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis BTerminatedPhase 4Bukwang PharmaceuticalNCT01264133Written as Clevudine, Adefovir
- Efficacy Optimizing Extension Study of Chronic Hepatitis B Patients With Inadequate Response to NUC TherapyStatus unknownPhase 4Nanfang Hospital, Southern Medical UniversityNCT01829685Written as Entecavir, Adefovir
- Adefovir and Lamivudine for Entecavir Resistance (ALTER Study)CompletedPhase 4Korea UniversityNCT01546116Written as ADEFOVIR, LAMIVUDINE
- Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant VirusCompletedPhase 3Bristol-Myers SquibbNCT00410202Written as Adefovir
- Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC TherapyStatus unknownPhase 4Nanfang Hospital, Southern Medical UniversityNCT01341743Written as Entecavir, Adefovir
- Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot StudyStatus unknownPhase 4Korea UniversityNCT01804387Written as telbivudine plus adefovir
- Telbivudine Renoprotective Effect in Patients With the HBV-related Liver Cirrhosis: a Randomized Controlled TrialStatus unknownPhase 4Lin BingliangNCT01799486Written as Adefovir
- Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B InfectionCompletedPhase 3Bristol-Myers SquibbNCT00096785Written as adefovir
- TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC)Status unknownPhase 2Tongji UniversityNCT00960518Written as adefovir
- Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B VirusTerminatedPhase 3PharmassetNCT00496158Written as Adefovir
- Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B VirusTerminatedPhase 3PharmassetNCT00496002Written as Adefovir
- Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected PatientsCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00013702Written as Adefovir
See all 22 studies that test adefovir →
Given in every arm · 6 — adefovir is usual care beside what is tested
- A Study of Peginterferon Alfa-2a [PEGASYS] in Patients With Chronic Hepatitis B Who Are HBeAg PositiveCompletedPhase 4Hoffmann-La RocheNCT01086085Written as Adefovir
- Compare Continuing Lamivudine Plus Adefovir or Adefovir Versus Switching to Entecavir Plus Adefovir in Patients With LAM-resistant Chronic Hepatitis BStatus unknownPhase 4Asan Medical CenterNCT02482272Written as Adefovir
- Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis BCompletedPhase 2Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT02366208Written as Adefovir
- Phase Ⅲ Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg-positive Chronic Hepatitis BStatus unknownPhase 3Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT02366247Written as Adefovir
- Entecavir Plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Patients Who Fail Lamivudine Plus AdefovirCompletedPhase 4Asan Medical CenterNCT01023217Written as Adefovir
- Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B PatientsTerminatedPhase 4Inje UniversityNCT00798460Written as adefovir
As the comparator · 8 — what is tested is compared with adefovir
- Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With TelbivudineCompletedPhase 3Novartis PharmaceuticalsNCT00640588Written as oral adefovir
- TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNACompletedPhase 4Keimyung University Dongsan Medical CenterNCT01732367Written as Lamivudine plus adefovir
- Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B PatientsStatus unknownPhase 4Taipei Veterans General Hospital, TaiwanNCT01491295Written as Lamivudine plus adefovir
- Efficacy Optimizing Research of Lamivudine TherapyCompletedPhase 4Nanfang Hospital, Southern Medical UniversityNCT01088009Written as lamivudine, adefovir
- Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic DecompensationCompletedPhase 3Bristol-Myers SquibbNCT00065507Written as Adefovir (ADV)
- An Study of Efficacy and Safety of ClevudineCompletedPhase 3Eisai Co., Ltd.NCT01192854Written as Adefovir
- Suboptimal Responders to Adefovir Switching to EntecavirCompletedPhase 4Bristol-Myers SquibbNCT00718887Written as Adefovir/Entecavir
- Phase I Study to Investigate the Safety and Efficacy of HBV DNA VaccineCompletedPhase 1Genexine, Inc.NCT00513968Written as Adefovir
Codes
What other systems call adefovir · ClinicalTrials.gg INT003330
- MeSH (NLM) C053001adefovirConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 6GQP90I798ADEFOVIRConfirmed FDA, NLM, Wikidata
- RxNorm 16521Confirmed FDA, Wikidata
- Wikidata Q353551adefovirConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61526AdefovirOne source FDA
- DrugBank DB13868One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C053001 | adefovir | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 6GQP90I798 | ADEFOVIR | Confirmed FDA, NLM, Wikidata |
| RxNorm | 16521 | — | Confirmed FDA, Wikidata |
| Wikidata | Q353551 | adefovir | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61526 | Adefovir | One source FDA |
| DrugBank | DB13868 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.